Flavonol

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameFlavonol
Drug Alias NameNP-202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP38 mitogen-activated protein kinase inhibitors
TargetsP38 mitogen-activated protein kinase
Therapy Area/IndicationsST Elevation Myocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArmaron Bio
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArmaron Bio Pty Ltd
Active IndicationsN/A
Inactive IndicationsST Elevation Myocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A